In agreement, CMM patients have higher circulating leptin levels at diagnosis [52] and melanoma tumour growth is higher in obese mice with high leptin levels and lower in lean leptin-deficient mice with restricted diet [53]. The gene discussed is LEP; the disease is neoplasm.